📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Alseres

1.1 - Company Overview

Alseres Logo

Alseres

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of diagnostic and therapeutic product development focused on disorders in the central.

Products and services

🔒

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Alseres

GeneTx Biotherapeutics Logo

GeneTx Biotherapeutics

HQ: United States Website
  • Description: Provider of biotechnology therapeutics focused on Angelman syndrome, offering investigational gene and antisense therapies. Pipeline includes GTX-102 for Angelman syndrome (delivering a functional UBE3A gene to the brain), UX055 for CDKL5 Deficiency Disorder, and UX111 for Sanfilippo syndrome type A, with a commitment to clinical trial transparency including trial registration, results publication, and data sharing.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full GeneTx Biotherapeutics company profile →
Audentes Therapeutics Logo

Audentes Therapeutics

HQ: United States Website
  • Description: Provider of gene therapy research and development for rare muscle diseases, serving as the Gene Therapy Center of Excellence with divisions in technical operations, medical and development, and future commercialization of gene therapy programs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Audentes Therapeutics company profile →
Immusoft Logo

Immusoft

HQ: United States Website
  • Description: Provider of cell therapies for sustained therapeutic protein delivery in rare diseases, using its Immune System Programming (ISP) platform to modify patients’ B cells to produce proteins over extended periods. Pipeline includes ISP-001 for MPS I (alpha-L-iduronidase) and ISP-002 for MPS II (iduronate sulfatase).
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Immusoft company profile →
Comet Therapeutics Logo

Comet Therapeutics

HQ: United States Website
  • Description: Provider of therapies designed to treat orphan neurological disorders; develops treatments to restore dysregulated CoEnzyme A metabolism through a CoEnzyme metabolism platform, enabling physicians to address profound unmet medical needs.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Comet Therapeutics company profile →
Modus Therapeutics Logo

Modus Therapeutics

HQ: Sweden Website
  • Description: Provider of sevuparin-based therapeutics in development to treat Sickle Cell Disease, sepsis/septic shock, and severe malaria, and to address anemia in chronic kidney disease and chronic inflammatory conditions; developing IV and subcutaneous formulations for hospital, ambulatory, and home care.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Modus Therapeutics company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Alseres

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Alseres

2.2 - Growth funds investing in similar companies to Alseres

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Alseres

4.2 - Public trading comparable groups for Alseres

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Alseres

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Alseres

What does Alseres do?

Alseres is a provider of diagnostic and therapeutic product development focused on disorders in the central.

Who are Alseres's competitors?

Alseres's competitors and similar companies include GeneTx Biotherapeutics, Audentes Therapeutics, Immusoft, Comet Therapeutics, and Modus Therapeutics.

Where is Alseres headquartered?

Alseres is headquartered in United States.

How many employees does Alseres have?

Alseres has 1,000 employees 🔒.

When was Alseres founded?

Alseres was founded in 2010 🔒.

What sector and industry vertical is Alseres in?

Alseres is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Alseres

Who are the top strategic acquirers in Alseres's sector and industry

Top strategic M&A buyers and acquirers in Alseres's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Alseres?

Top strategic M&A buyers groups and sectors for Alseres include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Alseres's sector and industry vertical

Which are the top PE firms investing in Alseres's sector and industry vertical?

Top PE firms investing in Alseres's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Alseres's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Alseres's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Alseres's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Alseres include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Alseres's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Alseres?

The key public trading comparables and valuation benchmarks for Alseres include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Alseres for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Alseres with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Alseres's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Alseres with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Alseres's' sector and industry vertical?

Access recent funding rounds and capital raises in Alseres's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Alseres